Answers are grounded in this paper and cite their sources.
Chemotherapy-induced nausea and vomiting remains a significant clinical challenge, adversely affecting nutritional status, treatment adherence and quality of life among patients undergoing cancer therapy. Despite advances in antiemetic protocols, a considerable proportion of patients continue to experience persistent nausea, highlighting the need for adjunctive strategies that address both symptom burden and nutritional compromise.
No takes yet. Share an insight, caveat, or question.
Preeti Lamba (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: